Literature DB >> 32216249

Fidelity in surgical simulation: further lessons from the S.T.A.R.T.T. course

Garrett G.R.J. Johnson1, Peter G. Brindley1, Lawrence M. Gillman1.   

Abstract

Summary: Simulation has become a popular and ubiquitous medical education tool. In response to learner demands, and because of technological advancement, there is a trend toward increasing the realism of simulation. However, there is a paucity of evidence regarding what degree of fidelity is needed to deliver optimal simulation-based medical education. Feedback from the Simulated Trauma And Resuscitation Team Training (S.T.A.R.T.T.) course suggests that higherfidelity simulation is viewed as highly valuable to learners. Research is needed in order to guide the growing demand for higher-fidelity simulation in our medical training curricula and in order to justify or mitigate the associated costs and logistical challenges.
© 2020 Joule Inc. or its licensors

Entities:  

Mesh:

Year:  2020        PMID: 32216249      PMCID: PMC7828954          DOI: 10.1503/cjs.017818

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  3 in total

Review 1.  Simulation in paediatric urology and surgery. Part 1: An overview of educational theory.

Authors:  Ramesh M Nataraja; Nathalie Webb; Pedro-Jose Lopez
Journal:  J Pediatr Urol       Date:  2018-03-01       Impact factor: 1.830

2.  Does laparoscopic simulation predict intraoperative performance? A comparison between the Fundamentals of Laparoscopic Surgery and LapVR evaluation metrics.

Authors:  Sarah N Steigerwald; Jason Park; Krista M Hardy; Lawrence M Gillman; Ashley S Vergis
Journal:  Am J Surg       Date:  2014-10-22       Impact factor: 2.565

3.  S.T.A.R.T.T. plus: addition of prehospital personnel to a national multidisciplinary crisis resource management trauma team training course.

Authors:  Lawrence M Gillman; Doug Martin; Paul T Engels; Peter Brindley; Sandy Widder; Cheryl French
Journal:  Can J Surg       Date:  2016-02       Impact factor: 2.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.